Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. DEXTENZA OPHTHALMIC INSERT 0.4 MG [SIN17195P]

DEXTENZA OPHTHALMIC INSERT 0.4 MG [SIN17195P]

Active ingredients: DEXTENZA OPHTHALMIC INSERT 0.4 MG

Last updated 26 October 2025

Product Info

DEXTENZA OPHTHALMIC INSERT 0.4 MG

[SIN17195P]

Product information

Active Ingredient and Strength

DEXAMETHASONE (MICRONIZED) - 0.4 MG

Dosage Form

INSERT, EXTENDED RELEASE

Manufacturer and Country

OCULAR THERAPEUTIX, INC. - UNITED STATES
ISOMEDIX OPERATIONS INC. DBA STERIS APPLIED STERILIZATION TECHNOLOGIES (CONTRACT STERILIZATION) - UNITED STATES

Registration Number

SIN17195P

Licence Holder

LABCORP DEVELOPMENT (ASIA) PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

S01BA01

2. INDICATIONS AND USAGE
2.1 Ocular Inflammation and Pain Following Ophthalmic Surgery
DEXTENZA (dexamethasone ophthalmic insert) is a corticosteroid indicated for the treatment of ocular inflammation and pain following ophthalmic surgery (Refer to Section 12.1 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

2.2 Itching Associated with Allergic Conjunctivitis
DEXTENZA (dexamethasone ophthalmic insert) is a corticosteroid indicated for the treatment of ocular itching associated with allergic conjunctivitis (Refer to Section 12.2 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

3. DOSAGE AND ADMINISTRATION
3.1. General Dosing Information
DEXTENZA is an ophthalmic insert that is inserted in the lower lacrimal punctum into the canaliculus. A single DEXTENZA insert releases a 0.4 mg dose of dexamethasone for up to 30 days following insertion.

DEXTENZA is resorbable and does not require removal. Saline irrigation or manual expression can be performed to remove the insert if necessary. DEXTENZA is intended for single-use only.

3.2. Administration
Do not use if pouch has been damaged or opened. Do not re-sterilize.

  1. Carefully remove foam carrier and transfer to a clean and dry area.

  2. If necessary, dilate the punctum with an ophthalmic dilator. Care should be taken not to perforate the canaliculus during dilation or insertion of DEXTENZA. If perforation occurs, do not insert DEXTENZA.

  3. After drying the punctal area, using blunt (non-toothed) forceps, grasp DEXTENZA and insert into the lower lacrimal canaliculus by pulling the lid temporally and inserting nasally.

  4. Ensure DEXTENZA is placed just below the punctal opening. Excessive squeezing of DEXTENZA may cause deformation.

  5. To aid in the hydration of DEXTENZA, 1 to 2 drops of balanced salt solution can be instilled into the punctum. DEXTENZA hydrates quickly upon contact with moisture. If DEXTENZA begins to hydrate before fully inserted, discard the product and use a new DEXTENZA.

  6. DEXTENZA can be visualized when illuminated by a blue light source (e.g., slit lamp or hand held blue light) with yellow filter.

4. CONTRAINDICATIONS
DEXTENZA is contraindicated in patients with active corneal, conjunctival or canalicular infections, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella; mycobacterial infections; fungal diseases of the eye, and dacryocystitis.